ULISES is set to develop an immunologic-based treatment strategy where cancer cells are reprogrammed to become “visible” to the patients’ immune system.
According to the statistics from the World Health Organization, cancer is the second leading cause of death globally, counting for approximately 9.6 million deaths in 2018. This figure is expected to increase by 60% by 2040 due to the ageing and increase of the world’s population.
While cancer treatments are currently based on surgical resection of the tumour (if possible), chemotherapy, radiotherapy, target-driven therapies and immunotherapy, ULISES aims to set out an all-new therapeutic strategy based on nanotechnologies.
If you’re just born in the wrong country, or social class, you may have a 60% less chance of surviving cancer. On World Cancer Day, experts call to fight “inequities”: not a matter of chance, but of modifiable factors which might save millions of lives.
Matthias Niemann, VP Technology of PIRCHE, explains in this interview how his company is contributing to the ULISES goals in the fight of cancer.
Developing art and creativity to improve the effectiveness and delivery of healthcare. From narrative medicine to the disclosure of one’s medical records on the net: how “open sourcing” feelings and fears can help fight cancer and reshape the concept of “cure”.
